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A large number of diverse bacterial species has been detected in samples taken
from the lungs of cystic ﬁbrosis (CF) patients. In order to understand the impact of
these species in terms of progression of CF lung disease, it is of vital importance
to determine to what extent they are also present in the healthy lung. The aim of
this study was i) to determine the degree to which the bacterial communities differ
between the two groups and ii) to identify any potential indicative consortia in
either lung type. To address this question, sputa were obtained from 18 CF patients
and induced from 18 healthy individuals. In these samples, bacterial species present
were assessed by the culture-independent strategy of Terminal Restriction Fragment
Length Polymorphism (T-RFLP) proﬁling of the phylogenetically informative 16S
rRNA gene. Statistical assessment showed the extent to which the bacteria were
present in either sample set differed; this difference was found to be highly
signiﬁcant (P< 0.001). By using both Dice and Jaccard measurements of similarity,
the bacterial communities in these samples demonstrated a close grouping according
to their disease status. On average, bacteria in both datasets were less than 20%
similar. Subsequent analyses will further focus on the nature of these differences
and determine whether particular species are characteristic for either group. The
signiﬁcance of these ﬁndings in relation to infection and, in the longer term, therapy
is also discussed.
Supported by: Anna Trust.
81 Audit of MRSA positive cultures at a UK adult CF centre
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Introduction: Papworth Hospital enforces strict cross-infection precautions through
cohort and individual segregation of in and out patients. The aim of this study was
to audit the incidence, prevalence and outcome of treatment of MRSA infection at
our centre.
Methods: All positive MRSA cultures between 2004 and 2007 were obtained
from computerised microbiology records of 189 non-transplant CF patients. Patient
hospital records were used to determine the actions taken for each positive culture
and its outcome.
Results: 72 samples from 19 patients grew MRSA: 63 sputum samples in
17 patients, 8 skin swabs in 6 patients and 1 blood culture thought due to skin
contamination in 1 patient. The incidence and prevalence respectively of patients
with MRSA positive sputum cultures were 1.3% and 4.0% in 2004; 3.6% and
6.8% in 2005, and 2.7% and 5.5% in 2006. Fourteen previously sputum positive
patients are currently MRSA negative. Eight of these have been MRSA negative for
more than a year: 4 were treated with long-term oxytetracycline, 1 with two weeks
of oxytetracycline, 1 with four weeks of trimethoprim and 2 with no treatment
following a single positive culture. Six patients have been MRSA negative for
between two and eleven months: 4 were treated with oxytetracycline, 1 with
trimethoprim and 1 with rifampicin.
Five patients have cleared MRSA from skin with Aquasept and Bactroban. Four
patients, 2.2% of our clinic, are chronically infected with MRSA (1 skin and 3
sputum). One patient works as a nurse and 2 patients are siblings. Oxytetracycline
caused GI side effects in three patients; two patients did not comply with QDS
dosing.
Conclusion: This audit shows a low incidence of MRSA infection at our centre.
Oxytetracycline appears to be an effective treatment for sputum MRSA infection
in CF adults.
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MRSA colonization/infection is increasingly found in patients with CF during last
years. The aim of our study was to determine some epidemiological features of
MRSA airway colonization/infection in our CF patients. We reviewed retrospec-
tively the clinical, demographic and laboratory data of the 440 CF patients who
attended our hospital between 01/2000–12/2006 for at least one year. During this
period 7785 sputum or deep throat specimens were cultured.
Results: (1) MRSA positive were 334 cultures, corresponding to 140 patients
(65 males and 75 females). (2) The mean age of patients at the 1st isolation
of MRSA was 7.1 y (SD: ±3.6). (3) 12 patients (8.6%) were persistently col-
onized/infected with MRSA (>3 years), 86 patients (61.4%) had contemporary
colonization, while 42 (30%) had short time colonization (<8 months). (4) Eight
different antibiotic resistance phenotypes were observed. The most prevalent phe-
notype was the one with resistance only to oxacillin (59.2%), followed by resistance
to oxacillin plus aminoglycosides (15.5%) and oxacillin plus erythromycin (8.5%).
Four patients (2.8%) were colonized/infected with multidrug resistant phenotype.
Conclusions: (1) The mean annual incidence rate during this period showed no
changes, but the mean age of 1st acquisition seems to decrease by time. (2) The
multidrug-resistant phenotypes are rare, for the time being. (3) Although MRSA
strains are often isolated from patients with CF, only a small proportion of this
population remains chronically colonized.
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Methicillin-resistant S. aureus (MRSA) is a major cause of both healthcare-
associated and community-associated infections. The prevalence of MRSA in Cystic
Fibrosis (CF) is increasing, and patients are considered at risk for cross-infection.
The present multicenter study investigates the susceptibility pattern, epidemiology
and SCCmec type of MRSA strains isolated from 9 Italian CF centres. The
susceptibility pattern was determined by disk diffusion method whereas Pulsed
Field Gel Electrophoresis (PFGE) was performed for epidemiological purposes.
SCCmec type was determined using molecular methods, and the Panton-Valentine
leukocidin (PVL) gene 1 was also tested. Thirty-one (17.1%) out of 181 analysed
MRSA strains belonged to the same PFGE clone shared among 6 centres. A good
susceptibility rate to trimethoprim-sulfamethoxazole and rifampin, suggestive of
CA-MRSA isolates, was found. Twenty-four (77.4%) out of 31 strains revealed a
SCCmec type IV, indicative for CA-MRSA, as suggested by the lower resistance
rates against tested drugs. All the clinical isolates belonging to the epidemic clone
were negative for the PVL genes.
Further studies are required to clarify the role of CA-MRSA in global epidemiology,
their pathogenicity and clinical impact on CF patients.
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